Frontage Holdings Corporation (FGHQF) Financials
FGHQF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 580.3 million | 222.2 million |
| Dec. 31, 2025 | 541.0 million | 191.0 million |
| June 30, 2025 | 544.3 million | 202.8 million |
| Dec. 31, 2024 | 553.6 million | 219.3 million |
FGHQF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| Dec. 31, 2025 | 15.5 million | 905000 |
| June 30, 2025 | 12.6 million | 1.1 million |
| Dec. 31, 2024 | 23.3 million | ? |
FGHQF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | ? |
| Dec. 31, 2025 | 8.7 million |
| June 30, 2025 | 2.9 million |
| Dec. 31, 2024 | 909864 |
FGHQF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 35.2 million | 47.9 million | 38.1 million |
| Dec. 31, 2025 | 39.1 million | 28.2 million | 51.9 million |
| June 30, 2025 | 33.7 million | 34.1 million | 58.2 million |
| Dec. 31, 2024 | 44.1 million | 44.4 million | 58.7 million |
FGHQF Shares Outstanding
FGHQF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 3.0 million | 21.7 million | - |
| Dec. 31, 2025 | 7.9 million | 2.1 million | 24.5 million | - |
| June 30, 2025 | 3.6 million | 2.2 million | 25.9 million | 4.3 million |
| Dec. 31, 2024 | 9.4 million | 2.8 million | 26.7 million | 3.8 million |
FGHQF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 147.8 million | 110.0 million |
| Dec. 31, 2025 | 130.4 million | 96.4 million |
| June 30, 2025 | 126.6 million | 91.3 million |
| Dec. 31, 2024 | 126.7 million | 91.7 million |
FGHQF
Price: $0.18
52 week price:
Earnings Per Share: 0.01 USD
P/E Ratio: 20.01
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 354.9 million